Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours?
- 26 August 2006
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 59 (5) , 637-642
- https://doi.org/10.1007/s00280-006-0306-6
Abstract
The aim of this trial was to evaluate the safety and efficacy of oxaliplatin and capecitabine (XELOX) in neuroendocrine tumours’ (NETs) treatment.Keywords
This publication has 17 references indexed in Scilit:
- Phase II/III Study of Doxorubicin With Fluorouracil Compared With Streptozocin With Fluorouracil or Dacarbazine in the Treatment of Advanced Carcinoid Tumors: Eastern Cooperative Oncology Group Study E1281Journal of Clinical Oncology, 2005
- Is the new WHO classification of neuroendocrine tumours useful for selecting an appropriate treatment?Annals of Oncology, 2005
- Oxaliplatin-Based Chemotherapy for the Treatment of a Metastatic Carcinoid TumorJournal of Gastrointestinal Cancer, 2005
- Treatment of neuroendocrine tumours with infusional 5-fluorouracil, folinic acid and streptozocinBritish Journal of Cancer, 2003
- Histological Typing of Endocrine TumoursPublished by Springer Nature ,2000
- Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatinBritish Journal of Cancer, 1999
- Treatment of metastatic carcinoids and other neuroendocrine tumors with recombinant interferon-alpha-2a: A study by the Italian trials in Medical Oncology GroupCancer, 1993
- Streptozocin–Doxorubicin, Streptozocin–Fluorouracil, or Chlorozotocin in the Treatment of Advanced Islet-Cell CarcinomaNew England Journal of Medicine, 1992
- Chemotherapy with 5-Fluorouracil and Streptozotocin in Carcinoid Tumors of Gastrointestinal Origin: Experiences with 13 PatientsJournal of Chemotherapy, 1991
- Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasmsCancer, 1991